Novartis India share price surged 18% in intra-day trade on Friday, February 20, after promoter Novartis AG agreed to sell its entire stake in the company, triggering a mandatory open offer and a complete change in...
Alkem Labs unit to buy up to 55% of Occlutech for $118 million
Alkem Laboratories’ medical devices unit will buy up to a 55% stake in Switzerland’s Occlutech Holding for 99.4 million euros ($118 million), the Indian pharma company said on Friday, marking its entry into...
Alkem Labs unit to buy up to 55% of Occlutech for $118 million
Alkem Laboratories’ medical devices unit will buy up to a 55% stake in Switzerland’s Occlutech Holding for 99.4 million euros ($118 million), the Indian pharma company said on Friday, marking its entry into...
USV Pharma leads race to buy 85% stake in Wellbeing Nutrition at Rs 1,600 crore valuation
USV Pharma has emerged as the frontrunner for acquiring an 85% stake in Wellbeing Nutrition, valuing the direct-to-consumer supplements brand at about Rs 1,600 crore, said people familiar with the discussions. The...
Warburg-Mubadala team up, emerge as frontrunner for Encube
A consortium of Warburg Pincus and Abu Dhabi sovereign wealth fund Mubadala has emerged as the frontrunner to acquire a majority stake of up to 74% in Mumbai-based Encube Ethicals, a generics and pharmaceutical contract...
Aurobindo Pharma board considers merger of subsidiaries
Approves the filing of scheme of merger of Auro Vaccines with Curateq Biologics The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger...
NATCO Pharma Asia acquires 49% stake in PT NATCO Lotus Farma
NATCO Pharma Asia, a wholly-owned subsidiary (WOS) of Natco Pharma (NATCO) incorporated in Singapore, has acquired 49% of the shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia. NATCO already owns 51% of...
Sun Pharma looks to rise in US with $10 billion Organon buy
Sun Pharmaceutical Industries Ltd, India’s largest drugmaker by market cap and revenue, is evaluating the acquisition of US-based Organon, a specialist in women’s health with an expanding presence in the fast-emerging...
AbbVie denies media reports of talks to buy Revolution Medicines
AbbVie on Wednesday denied it was in talks to buy Revolution Medicines after the Wall Street Journal reported the drugmaker was in advanced discussions to acquire the cancer-drug developer. The company “is not in...
Aurobindo arm to acquire additional 20% stake in JV firm
Aurobindo Pharma on Tuesday said that it will pick up an additional 20 per cent stake in its China-based joint venture for USD 5.12 million. Helix Healthcare BV, a wholly-owned subsidiary of the company, has entered...
Sweden’s Sobi to buy US biotech Arthrosi for up to $1.5 billion to boost gout pipeline
Drugmaker Swedish Orphan Biovitrum said on Saturday it had agreed to acquire U.S.-based biotechnology company Arthrosi Therapeutics for up to $1.5 billion to strengthen its portfolio of gout treatments. Sobi will pay...
Mirum to buy Bluejay for up to $820 million in bet on liver-disease drug
Mirum Pharmaceuticals said on Monday it will buy Bluejay Therapeutics in a deal worth up to $820 million, adding a late-stage experimental drug for a severe liver disease. The deal will give the company worldwide rights...
